Back to All Studies

Feline herpesvirus-1 (FHV-1) accounts for approximately 50% of all diagnosed viral upper airway infections and is a major cause of eye infections in cats. Current FHV-1 vaccines are a component of core (recommended) vaccinations. While core vaccines provide satisfactory protection against infection for other common cat viruses, including feline calicivirus (FCV) and feline panleukopenia virus (FPV), protection from FHV-1 is limited and short in duration. To address this problem and reduce the need for multiple core vaccinations, researchers will develop a new three-in-one vaccine that is safe and can provide superior protection from FHV-1, in addition to protection from FCV and FPV. The team hopes their new vaccine will provide long-lasting immunity against all three common cat pathogens.

Study ID
D22FE-038
Study Status
Active
Start Date
02/01/2022
Grant amount awarded
$74,886
Grant recipient
Michigan State University
Study country
United States
Investigator
Gisela Soboll Hussey, DVM, PhD
Study category
Infectious Disease